Sensochek 0.5% Eye Drop
Sensochek 0.5% Eye Drop belongs to the aminoester group and is mostly used as a topical anaesthetic medication. The drug affects the nerves, in order to reduce pain and cause numbness for certain treatment procedures.
Sensochek 0.5% Eye Drop should not be used if you are allergic to any of the ingredients contained in proparacaine drops. Some medicines may react with Sensochek 0.5% Eye Drop, therefore proper medical help must be sought if you are pregnant, breastfeeding or allergic to certain ingredients.
Possible side effects may include a temporary irritation or burning sensation in the eyes, disturbances in vision, rashes, swelling in the mouth, eyes, lips or face as an allergic reaction or difficulty in breathing. However, in case of any severity, you must consult a doctor as soon as possible. The incorrect use or prolonged use may even lead to visual loss or cause corneal opacification permanently.
Do not exceed the advised dosage or prolong the use of Sensochek 0.5% Eye Drop without consulting the medical expert. Try to prevent any contamination of the medicine and in case of any change in the usual straw-coloured surface of the drug, immediately stop use. The drug is meant for topical application only and not to be injected.
Is It safe with alcohol?No interaction found
Are there any pregnancy warnings?Topicaine eye drop may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Are there any breast-feeding warnings?Unknown. Human and animal studies are not available. Please consult your doctor.
Is it safe to drive while on this medicine?There is no data available. Please consult doctor before consuming the drug.
Does this affect kidney function?There is no data available. Please consult doctor before consuming the drug.
Does this affect liver function?There is no data available. Please consult doctor before consuming the drug.
This medication works by changing the epithelial sodium pathways via interaction with channel protein residues. Due to this the primary alteration required for the production of the action potential is inhibited. Therefore, an electrical impulse is not generated during anaesthesia.
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.